- Recent Advances in Melanoma Therapy
- Targeted Treatments and Immunotherapies for Melanoma
- Tailoring Treatments in Melanoma
- Drug Resistance in Melanoma
- Affordability of Melanoma Care
- Melanoma: Treatment-induced Toxicity
- Immunotherapy: A Decade of Improvements in ...
- Should Patients With Melanoma Receive Targeted ...
- Melanoma: Checkpoints in the Pipeline
- Targeting Therapy for Melanoma Subtypes
- Melanoma: Targetable Genes in the Pipeline
- Clinical Trials in Melanoma
Skin Cancer News
Immune-Related Adverse Events Due to Checkpoint Inhibition Are More Common in Melanoma Than in NSCLC
More Skin Cancer Information
All meta-analyses conducted to date show a significant association between indoor tanning use and an increased risk of melanoma or non-melanoma skin cancers.
Prevention and early detection are the best ways to keep your skin healthy.
This fact sheet offers tips to decrease the risk of malignant melanoma, the fastest growing forms of skin cancer.
This patient fact sheet provides patients with information on the causes of melanoma along with ways to protect against it and find support in the event of a diagnosis.
This patient fact sheet describes risk factors and preventative measures in skin cancer, malignant melanoma.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Are Next-Gen Antibody-Drug Conjugates a Path Forward for Non-Hodgkin Lymphoma and Myeloma?
- Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis
- Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
- Apalutamide Does Not Diminish Quality of Life in Nonmetastatic Castration-Resistant Prostate Cancer
- Treatment Delays May Mean Worse Survival in Head and Neck Cancer
- FDA-Approved Breast Cancer Drug Treatments
- A Trained Dog Smells Early-Stage Lung Cancer With a High Degree of Accuracy
- FDA-Approved Colorectal Cancer Drug Treatments
- Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
- Emetogenic Potential of Antineoplastic Agents
- Combination Abiraterone Acetate, Radium-223 Not Recommended in CRPC With Bone Mets
- Brigatinib Found More Effective for ALK-positive NSCLC Brain Mets Compared With Crizotinib
- Higher Baseline AFP Linked to Greater Benefit With Cabozantinib in Hepatocellular Carcinoma
- Real-World Study Shows High Response Rates to T-VEC in Early Metastatic Melanoma
- A Big BiTE: Tetravalent BiTE Highly Potent in HER2-positive Breast Cancer Models